New York · 2025-2026 session · house
A 2650Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
- Status
- In committee
- Latest action
- — REFERRED TO INSURANCE
- Primary sponsor
- Nader Sayegh (Democratic)
Sponsors
- Nader Sayegh (Democratic) · primaryprimary
Versions
- A2650—